نتائج البحث - Kim Cocks

  • يعرض 1 - 20 نتائج من 20
تنقيح النتائج
  1. 1
    Can staff and patient perspectives on hospital safety predict harm-free care? An analysis of staff and patient survey data and routinely collected outcomes

    Can staff and patient perspectives on hospital safety predict harm-free care? An analysis of staff and patient survey data and routinely collected outcomes حسب Rebecca Lawton, Jane O’Hara, Laura Sheard, Caroline Reynolds, Kim Cocks, Gerry Armitage, John Wright

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30

    Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 حسب Kim Cocks, Madeleine King, Galina Velikova, Gilberto de Castro, Marrissa Martyn St-James, Peter Fayers, Julia Brown

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients

    Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients حسب Kate Sully, Andrew Trigg, Nicola Bonner, Alejandro Moreno‐Koehler, Claire Trennery, Nina Shah, Emre Yücel, Sumeet Panjabi, Kim Cocks

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial

    Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial حسب Galina Velikova, Ada Keding, Clare Harley, Kim Cocks, Laura Booth, Adam B. Smith, Penny Wright, Peter J. Selby, Julia Brown

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Can patient involvement improve patient safety? A cluster randomised control trial of the Patient Reporting and Action for a Safe Environment (PRASE) intervention

    Can patient involvement improve patient safety? A cluster randomised control trial of the Patient Reporting and Action for a Safe Environment (PRASE) intervention حسب Rebecca Lawton, Jane O’Hara, Laura Sheard, Gerry Armitage, Kim Cocks, Hannah Buckley, Belén Corbacho, Caroline Reynolds, Claire Marsh, Sally Moore, Ian Watt, John Wright

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Minimally important differences for interpreting the EORTC QLQ‐C30 in patients with advanced colorectal cancer treated with chemotherapy

    Minimally important differences for interpreting the EORTC QLQ‐C30 in patients with advanced colorectal cancer treated with chemotherapy حسب Jammbe Z. Musoro, Samantha C. Sodergren, Corneel Coens, Alessia Pochesci, M. Terada, Madeleine King, Mirjam A. G. Sprangers, M. Groenvold, Kim Cocks, Galina Velikova, Hans‐Henning Flechtner, Andrew Bottomley

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer

    Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer حسب Jammbe Z. Musoro, Corneel Coens, Frédéric Fiteni, Katarzyna Pogoda, Fátima Cardoso, Nicola S. Russell, Madeleine King, Kim Cocks, Mirjam A. G. Sprangers, Mogens Grøenvold, Galina Velikova, Hans‐Henning Flechtner, Andrew Bottomley

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol

    Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol حسب Zebedee Jammbe Musoro, Jean‐François Hamel, Divine Ediebah, Kim Cocks, Madeleine King, Mogens Grøenvold, Mirjam A. G. Sprangers, Yvonne Brandberg, Galina Velikova, John Maringwa, Hans‐Henning Flechtner, Andrew Bottomley, Corneel Coens

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer

    Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and n... حسب Jammbe Z. Musoro, Corneel Coens, Susanne Singer, Silke Tribius, Sjoukje F. Oosting, Mogens Grøenvold, Christian Simon, Jean‐Pascal Machiels, Vincent Grégoire, Galina Velikova, Kim Cocks, Mirjam A. G. Sprangers, Madeleine King, Andrew Bottomley

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia

    International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lym... حسب Lonneke V. van de Poll‐Franse, Simone Oerlemans, Anne Brédart, Charalampia Kyriakou, Monika Sztankay, Stephan Pallua, Laurien Daniëls, Carien L. Creutzberg, Kim Cocks, Sandra Malak, Giovanni Caocci, Stefano Molica, Wei‐Chu Chie, Fabio Efficace

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Improving patient safety through the involvement of patients: development and evaluation of novel interventions to engage patients in preventing patient safety incidents and protecting them against unintended harm

    Improving patient safety through the involvement of patients: development and evaluation of novel interventions to engage patients in preventing patient safety incidents and protec... حسب John Wright, Rebecca Lawton, Jane O’Hara, Gerry Armitage, Laura Sheard, Claire Marsh, Angela Grange, Rosemary McEachan, Kim Cocks, Susan Hrisos, Richard Thomson, Vikram Jha, Liz Thorp, Michael Conway, Ashfaq Gulab, Peter Walsh, Ian Watt

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer

    Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer حسب Kim Cocks, Jane R. Wells, Colin A. Johnson, Heike Schmidt, Michael Koller, Simone Oerlemans, Galina Velikova, Monica Pinto, Krzysztof A. Tomaszewski, Neil K. Aaronson, Elizabeth Exall, Chelsea Finbow, Deborah Fitzsimmons, Laura Grant, Mogens Grøenvold, Chloe Tolley, Sally Wheelwright, Andrew Bottomley

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

    First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial حسب Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, Kim Cocks, Sue Bell, Alex J. Szubert, Nuria Navarro-Coy, Mark T. Drayson, Roger G. Owen, Sylvia Feyler, A. John Ashcroft, Fiona Ross, Jenny Byrne, Huw Roddie, Claudius Rudin, Gordon Cook, Graham Jackson, J. Anthony Child

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma

    Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexam... حسب A. Keith Stewart, Meletios Α. Dimopoulos, Tamás Masszi, Ivan Špıčka, Albert Oriol, Roman Hájek, Laura Rosiñol, David S. Siegel, Rubén Niesvizky, Andrzej Jakubowiak, Jesús F. San Miguel, Heinz Ludwig, Jacqui Buchanan, Kim Cocks, Xinqun Yang, Biao Xing, Naseem J. Zojwalla, Margaret Tonda, Philippe Moreau, Antonio Palumbo

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping

    Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping حسب David C. Johnson, Sophie L. Corthals, Christine Ramos, Antje Hoering, Kim Cocks, Nicholas J. Dickens, Jeff Haessler, H. Goldschmidt, J. Anthony Child, Sue Bell, Graham Jackson, Dalsu Baris, S. Vincent Rajkumar, Faith E. Davies, Brian G.M. Durie, John Crowley, Pieter Sonneveld, Brian Van Ness, Gareth J. Morgan

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

    Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised cont... حسب Gareth J. Morgan, J. Anthony Child, Walter M. Gregory, Alex J. Szubert, Kim Cocks, Sue Bell, Nuria Navarro-Coy, Mark T. Drayson, Roger G. Owen, Sylvia Feyler, A. John Ashcroft, Fiona M. Ross, Jenny Byrne, Huw Roddie, Claudius Rudin, Gordon Cook, Graham Jackson, Ping Wu, Faith E. Davies

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types

    Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types حسب Jammbe Z. Musoro, Corneel Coens, Mirjam A. G. Sprangers, Yvonne Brandberg, Mogens Grøenvold, Hans‐Henning Flechtner, Kim Cocks, Galina Velikova, Linda Dirven, Elfriede Greimel, Susanne Singer, Katarzyna Pogoda, Eva‐Maria Gamper, Samantha C. Sodergren, Alexander M.M. Eggermont, Michael Koller, Jaap C. Reijneveld, Martin Taphoorn, Madeleine King, Andrew Bottomley

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

    Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related qua... حسب Kevin J. Harrington, Robert L. Ferris, George R. Blumenschein, A. Dimitrios Colevas, Jérôme Fayette, Lisa Licitra, Stefan Kasper, Caroline Even, Everett E. Vokes, Francis P. Worden, Nabil F. Saba, Naomi Kiyota, Robert I. Haddad, Makoto Tahara, Viktor Grünwald, James W. Shaw, Manish Monga, Mark Lynch, Fiona Taylor, Michael DeRosa, L Morrissey, Kim Cocks, Maura L. Gillison, J. Guigay

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review

    Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review حسب Madeline Pe, Lien Dorme, Corneel Coens, Ethan Basch, Melanie Calvert, Alicyn Campbell, Charles S. Cleeland, Kim Cocks, Laurence Collette, Linda Dirven, Amylou C. Dueck, Nancy Devlin, Hans‐Henning Flechtner, Carolyn Gotay, Ingolf Griebsch, Mogens Grøenvold, Madeleine King, Michael Koller, Daniel C. Malone, Francesca Martinelli, Sandra A. Mitchell, Jammbe Z. Musoro, Kathy Oliver, Elisabeth Piault‐Louis, Martine Piccart, Francisco Pimentel, Chantal Quinten, Jaap C. Reijneveld, Jeff A. Sloan, Galina Velikova, Andrew Bottomley

    منشور في 2018
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire

    International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire حسب Samantha C. Sodergren, Colin D. Johnson, Alexandra Gilbert, Anne‐Sophie Darlington, Kim Cocks, Marianne G. Guren, Eleonor Rivin del Campo, Christine Brannan, Peter Christensen, William Chu, Hans T. Chung, Kristopher Dennis, Isacco Desideri, Duncan C. Gilbert, R. Glynne‐Jones, Michael Jefford, Mia Johansson, Anders Johnsson, Therese Juul, Dimitrios Kardamakis, Julia Lai‐Kwon, Vicky McFarlane, Isalia M.C. Miguel, Karen Nugent, Femke P. Peters, Rachel P. Riechelmann, N. S. Turhal, C. Shun Wong, Vassilios Vassiliou

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: